Prescription of aspirin for adults with diabetes

Sabitha, P.; Kamath, Asha; Adhikari, Prabha

doi:10.4103/0973-3930.43099

Cited by 5 publications

(4 citation statements)

References 9 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This was similar to previous studies that reported both types of medications were commonly omitted in elderly patients. 7,9,11,20,21 The prevalence of under-prescription of aspirin for primary prevention of CVD, which was the most common omitted medication in elderly type 2 diabetic patients in this study, was close to a previous study by Sabitha et al 22 The reason may be because that article used the criteria for under-prescription based on the Thai diabetes guideline of 2014. For the use of aspirin, the guideline gives a moderate recommendation based on evidence from previous studies that showed the benefit of aspirin in the primary prevention of CVD.…”

Section: Discussionsupporting

confidence: 81%

“…This result was consistent with the low prevalence of under-prescription of aspirin and statins for secondary prevention of cardiovascular events in this study which was similar with a previous study. 22 The strength of this study is that it is one of the few studies on under-prescription in elderly type 2 diabetic patients. The results can bring improvements in the quality in the care of diabetic patients in this setting.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Under-Prescription in Elderly Type 2 Diabetic Patients in the Primary Care Unit of a University Hospital

Ananchaisarp

Duangkamsee

Burapakiat

et al. 2018

J Health Sci Med Res

View full text Add to dashboard Cite

Objectives: This study aimed to assess the prevalence of under-prescription among elderly type 2 diabetic patients in the primary care unit of a university hospital in southern Thailand and identify the associated factors.Material and Methods: A 1-year retrospective medical record review was conducted in elderly type 2 diabetic patients treated continuously in the primary care unit. Under-prescription was the primary outcome assessed from criteria developed from the START criteria (2015), Thailand’s clinical practice guideline for diabetes (2014), and for hypertension (2015).Results: This study included 458 medical records that fit our inclusion criteria. The median age was 69.1 years old and more than 80% of them had a comorbidity of dyslipidemia or hypertension. The prevalence of under-prescription in elderly type 2 diabetic patients was 84.5%. The most commonly omitted medication was aspirin for primary prevention of cardiovascular disease. An increased number of medications received and having cardiovascular disease was associated with a lower risk of under-prescription.Conclusion: The prevalence of the omission of beneficial medications in elderly type 2 diabetic patients in the primary care unit of a university hospital was high, especially under-prescription of aspirin for primary prevention of cardiovascular disease.

show abstract

Section: Discussionsupporting

confidence: 81%

Section: Discussionmentioning

confidence: 99%

Prevalence of Under-Prescription in Elderly Type 2 Diabetic Patients in the Primary Care Unit of a University Hospital

Ananchaisarp

Duangkamsee

Burapakiat

et al. 2018

J Health Sci Med Res

View full text Add to dashboard Cite

show abstract

“…The prevalence of previous antiplatelet use before the current stroke attack among diabetic patients was 38.3%, with most (69.9%) on aspirin as monotherapy. This prevalence was lower than that reported in some studies that included all diabetic patients from the US (54%), the UK (52%), India (100%), and in diabetic patients with cardiovascular disease from Palestine (56.9%) [12,13,14,24].…”

Section: Discussionmentioning

confidence: 57%

Antiplatelet therapy in diabetic ischemic stroke patients: associated factors and outcomes

Al-Jabi¹,

Aziz²,

Looi³

et al. 2011

View full text Add to dashboard Cite

Background: Patients with diabetes mellitus (DM) are more prone to develop atherosclerotic complications including stroke. Moreover, as a primary and secondary prevention of stroke, antiplatelet therapy is recommended by clinical guidelines for patients with DM. Aims: This study aimed to determine the prevalence of antiplatelet therapy use prior to current stroke in diabetic ischemic stroke patients, to examine the factors associated with the use of this important therapy and to assess the impact of the previous use of antiplatelet therapy on ischemic stroke outcomes. Methods: An observational study of diabetic acute ischemic stroke patients attending a Malaysian hospital during a 1-year period was carried out. Demographic information, risk factors, previous antiplatelet use and variables used to assess stroke outcomes were collected from medical records. Results: Overall, 295 diabetic stroke patients were analyzed. The prevalence of previous antiplatelet use among diabetic patients was 38.3%. The independent variables associated with the previous use of antiplatelet medication were previous stroke attack (p < 0.001) and ischemic heart disease (p < 0.001). Better outcomes as measured by a minor Glasgow Coma Scale at admission (p = 0.032), and a higher Modified Barthel index at discharge (p = 0.027) were observed among patients on previous antiplatelet therapy. Conclusion: Our data suggest that antiplatelet therapy is under prescribed among such diabetic stroke patients, particularly in primary prevention. Effective methods to increase antiplatelet use and to enhance the adherence of clinical practice guidelines should be considered at the national and community level.

show abstract

“…This result is higher when compared to the study conducted in Saudi Arabia, of 312 patients, aspirin was indicated for 17.0% but it was not prescribed; it was both indicated and prescribed in 36.2% of the cases [1]. When compared to the study conducted in India [21], 11% of patients were prescribed with an indication for a primary prevention which is similar with this study, 10.6%; however, 10% of the patients were not utilized despite indicated for a primary prevention which is higher than this study (3.6%) and there was no documentation for the reasons not using aspirin while this study found that 55.2% of patients were reasoned “not prescribed” .…”

Section: Discussionmentioning

confidence: 80%

The prevalence of low dose aspirin use for prevention of adverse cardiovascular events and its associated factors among patients with diabetes mellitus: A hospital based cross-sectional study

Tukeni

Mohammed

Regassa³

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Cardiovascular diseases (CVD) are the most common causes of mortality and morbidity among diabetic patients. Aspirin is recommended for primary and secondary prevention of cardiovascular events in patients with diabetics who are eligible for therapy based on active international guidelines. However, these active guidelines are underutilized. Hence, this article helps to assess low dose aspirin use and its associated factors in patients with diabetes mellitus on follow-up at the diabetes clinic of Jimma Medical Center (JMC). Method A cross-sectional study was conducted among 388 diabetic patients on follow-up at the diabetic clinic of JMC during October 1, 2020 to November 15, 2020. The collected data were cleaned and entered into EpiData version 4.6 then exported to STATA version 16.0 for analysis. Descriptive statistics and multivariable logistic regression was employed to identify the relationship between dependent and independent variables with declaring statistical significance if P value is less than 0.05. Result Out of the total 388 diabetic patients interviewed, Most of the patients were in the age group of 50-54 (35.8%) with the mean age of 48.8 [48.2, 51.4] years old. About half (48.7%) of them had a history of hypertension. Nearly double of the study participants (47.2%) were utilizing a low dose aspirin. Aspirin was indicated for 80 (20.6%) of the patients despite 21 (26.2%) of them were not using it. It was both indicated and prescribed in 59 (15.2%) of the cases. Older age, longer duration of DM, dyslipidemia, and hypertension were associated with more likely utilization of low dose aspirin. Conclusion About half of the DM patients were utilizing low dose aspirin, while only one fifth of them were having indications to do so. Furthermore, one fourth of the patients were not taking low dose aspirin for the prevention of cardiovascular events despite they were supposed to use it. Therefore, these findings suggest a greater need for physicians to carefully assess the indications to prescribe aspirin with a clear explanation of the it’s advantages in these specific patient population. Ultimately, future studies should examine the influence of updating guidelines on clinician behaviors to avoid irrational use of aspirin and the association of changing trends in preventive aspirin use with the development of CVD in patients with DM.

show abstract

Prescription of aspirin for adults with diabetes

Cited by 5 publications

References 9 publications

Prevalence of Under-Prescription in Elderly Type 2 Diabetic Patients in the Primary Care Unit of a University Hospital

Prevalence of Under-Prescription in Elderly Type 2 Diabetic Patients in the Primary Care Unit of a University Hospital

Antiplatelet therapy in diabetic ischemic stroke patients: associated factors and outcomes

The prevalence of low dose aspirin use for prevention of adverse cardiovascular events and its associated factors among patients with diabetes mellitus: A hospital based cross-sectional study

Contact Info

Product

Resources

About